- Dementia expert says evidence behind Biogen Alzheimer’s drug ‘wasn’t sufficient’ for FDA approvalCNBC
- US approves first new Alzheimer’s drug in 20 years – BBC NewsBBC News
- FDA approves Biogen Alzheimer’s treatmentCNBC Television
- Approving Biogen’s Alzheimer’s Drug Aducanumab (Aduhelm) Is Big MistakeBloomberg
- Why Cassava Sciences Was Up 15% in MayMotley Fool
- View Full Coverage on Google News